Clinical Trial Update: A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months [Phase 4]

View source ↗

Summary

This is a Phase 4 trial update examining adrenal function in hypogonadal men treated with JATENZO for 12 months; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• JATENZO (testosterone undecanoate)

Snippet

Sponsor: Tolmar Inc. | Conditions: Hypogonadism | Phase 4 | Status: ACTIVE_NOT_RECRUITING